Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant

Bone Marrow Transplantation

Volumn 40, Issue 6, 2007, Pages 573-578

  Soule, B P ^a   Simone, N L ^a   Savani, B N ^b   Ning, H ^a   Albert, P S ^a   Barrett, A J ^b   Singh, A K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; FLUDARABINE; INFLIXIMAB; STEROID;

ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG FUNCTION TEST; LUNG INJURY; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RADIATION INJURY; RADIATION PROTECTION; RADIATION SHIELD; SCHOOL CHILD; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIATION INJURIES; RADIATION PROTECTION; RESPIRATORY FUNCTION TESTS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 34548526852     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705771     Document Type: Article

References (45)

1. Shim BY, Lee MA, Byun JH, Roh SY, Song CW, Park JN et al. High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: A single-center experience of 50 patients. Korean J Intern Med 2004; 19: 114-120.
2. Reimer P, Schertlin T, Rudiger T, Geissinger E, Roth S, Kunzmann V et al. Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: First results of a prospective multicenter study. Hematol J 2004; 5: 304-311.
3. Kang HJ, Shin HY, Choi HS, Han KS, Ahn HS. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia. Bone Marrow Transplant 2004; 33: 471-476.
4. Russell-Jones R, Child F, Olavarria E, Whittaker S, Spittle M, Apperley J. Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: Predictors of disease-free survival. Ann NY Acad Sci 2001; 941: 147-154.
5. Varterasian M, Janakiraman N, Karanes C, Abella E, Uberti J, Dragovic J et al. Transplantation in patients with multiple myeloma: A multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant. Am J Clin Oncol 1997; 20: 462-466.
6. Giralt SA, LeMaistre CF, Vriesendorp HM, Andersson BS, Dimopoulos M, Gajewski J et al. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. J Clin Oncol 1994; 12: 1923-1930.
7. Thomas ED. Total body irradiation regimens for marrow grafting. Int J Radiat Oncol Biol Phys 1990; 19: 1285-1288.
8. Advisory Committee of the International Bone Marrow Transplant Registry. Report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1989; 4: 221-228.
9. McAfee SL, Powell SN, Colby C, Spitzer TR. Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy. Int J Radiat Oncol Biol Phys 2002; 53 151-156.
10. Blaise D, Maraninchi D, Archimbaud E, Reiffers J, Devergie A, Jouet JP et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: A report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood 1992; 79: 2578-2582.
11. Dusenbery KE, Steinbuch M, McGlave PB, Ramsay NK, Blazar BR, Neglia JP et al. Autologous bone marrow transplantation in acute myeloid leukemia: The University of Minnesota experience. Int J Radiat Oncol Biol Phys 1996; 36: 335-343.
12. Ringden O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindelov L et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 2723-2730.
13. Boutard P, Reman O, Lemerle S, Guihard J. A relapse in the eye of acute lymphoblastic leukemia. Ann Pediatr (Paris) 1989; 36: 267-268.
14. Inoue T, Ikeda H, Yamazaki H, Tang JT, Song C, Teshima T et al. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission. Strahlenther Onkol 1993; 169: 250-255.
15. Shank B. The balancing act: Pneumonitis vs relapse in cytoreductive regimens containing total body irradiation. Int J Radiat Oncol Biol Phys 1996; 36: 261-262.
16. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation, Chest 1996; 109: 1066-1077.
17. Molls M, Budach V, Bainberg M. Total body irradiation: The lung as critical organ. Strahlenther Onkol 1986; 162: 226-232.
18. Cardozo BL, Zoetelief H, van Bekkum DW, Zurcher C, Hagenbeek A. Lung damage following bone marrow transplantation: I. The contribution of irradiation. Int J Radiat Oncol Biol Phys 1985; 11: 907-914.
19. Thomas O, Mahe M, Campion L, Bourdin S, Milpied N, Brunet G et al. Long-term complications of total body irradiation in adults. Int J Radiat Oncol Biol Phys 2001; 49: 125-131.
20. Malicki J, Skrobala A, Kosicka G, Wachowiak J. The efficacy and reliability of lung protection during total body irradiation of patients with disseminated malignancies. Neoplasma 2005; 52: 325-329.
21. Hirabayashi N, Goto S, Ishii M, Yuge M, Mitsuma A, Noda N. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia. Bone Marrow Transplant 1998; 21: 1079-1083.
22. Beyzadeoglu M, Oysul K, Dirican B, Arpaci F, Balkan A, Surenkok S et al. Effect of dose-rate and lung dose in total body irradiation on interstitial pneumonitis after bone marrow transplantation. Tohoku J Exp Med 2004; 202: 255-263.
23. Theuws JC, Kwa SL, Wagenaar AC, Seppenwoolde Y, Boersma LJ, Damen EM et al. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol 1998; 49: 233-243.
24. Della Volpe A, Ferreri AJ, Annaloro C, Mangili P, Rosso A, Calandrino R et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys 2002; 52: 483-488.
25. Theuws JC, Kwa SL, Wagenaar AC, Boersma U, Damen EM, Muller SH et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 1998; 48: 33-43.
26. Lohr F, Wenz F, Schraube P, Flentje M, Haas R, Zierhut D et al. Lethal pulmonary toxicity after autologous bone marrow transplantation/ peripheral blood stem cell transplantation for hematological malignancies. Radiother Oncol 1998; 48: 45-51.
27. Gopal R, Ha CS, Tucker SL, Khouri IF, Giralt SA, Gajewski JL et al. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity. Cancer 2001; 92 1949-1958.
28. Labar B, Bogdanic V, Nemet D, Mrsic M, Vrtar M, Grgic-Markulin L et al. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 9: 343-347.
29. Vriesendorp HM, Chu H, Ochran TG, Besa PC, Champlin RE. Radiobiology of total body radiation. Bone Marrow Transplant 1994; 14 (Suppl 4): S4-S8.
30. Tait RC, Burnett AK, Robertson AG, McNee S, Riyami BM, Carter R et al. Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: Relationship to total body irradiation and graft-versus-host disease. Int J Radiat Oncol Biol Phys 1991; 20: 1219-1227.
31. Socie G, Devergie A, Girinsky T, Reiffers J, Vernant JP, Le Bourgeois JP et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO). Int J Radiat Oncol Biol Phys 1991; 20: 397-404.
32. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
33. Shank B, Chu FC, Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H et al. Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants. Int J Radiat Oncol Biol Phys 1983; 9: 1607-1611.
34. Latini P, Aristei C, Aversa F, Checcaglini F, Maranzano E, Raymondi C et al. Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. Radiother Oncol 1991; 22: 127-132.
35. Singh AK, Karimpour SE, Savani BN, Guion P, Hope AJ, Mansueti JR et al. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogenic peripheral blood stem cell transplant. Int J Radiat Oncol Biol Phys 2006; 66: 520-527.
36. Crawford SW, Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest 1992; 101: 1257-1264.
37. Carlson K, Backlund L, Smedmyr B, Oberg G, Simonsson B. Pulmonary function and complications subsequent to autologous bone marrow transplantation. Bone Marrow Transplant 1994; 14: 805-811.
38. Chien JW, Maris MB, Sandmaier BM, Maloney DG, Storb RF, Clark JG. Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 288-296.
39. Solomon SR, Nakamura R, Read EJ, Leitman SF, Carter C, Childs R et al. Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 31: 783-788.
40. Nakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant 2004; 10: 49-57.
41. Cotes J. Lung Function, Assessment and Application in Medicine, 5th edn. Blackwell Scientific Publications: Cambridge, MA, 1993.
42. Weshler Z, Breuer R, Or R, Naparstek E, Pfeffer MR, Lowental E et al. Interstitial pneumonitis after total body irradiation: Effect of partial lung shielding. Br J Haematol 1990; 74: 61-64.
43. Ellis ER, Marcus Jr RB, Cicale MJ, Springfield DS, Bova FJ, Graham-Pole J et al. Pulmonary function tests after whole-lung irradiation and doxorubicin in patients with osteogenic sarcoma. J Clin Oncol 1992; 10: 459-463.
44. Gore EM, Lawton CA, Ash RC, Lipchik RJ. Pulmonary function changes in long-term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1996; 36: 67-75.
45. Savani BN, Montero A, Srinivasan R, Singh A, Shenoy A, Mielke S et al. Chronic GVHD and pre-transplant abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long term survivors after stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 1261-1269.